Blog: Life Technologies Signs Collaborative Agreement with Structural Genomics Consortium to Develop First Antibody Master Set for Epigenetic Studies

Pioneering joint venture releases 58 of 200 planned, highly-specific recombinant antibodies

New Collaborative Agreement - Life Technologies has signed a collaborative partnership with the Structural Genomics Consortium (SGC), and several groups of leading expert scientists in antibody technology at the Universities of Chicago and Toronto, to generate a first-ever master set of quality epigenetic recombinant antibodies for use in disease-related research. Read More

Date Posted: 07/20/12

Blog: Life Technologies Moving "Off the Grid" with Clean Energy Fuel Cells


Energy Efficiency Announcement - Life Technologies will use a fuel cell system to self-generate electricity at the company headquarters in Carlsbad, California. The Bloom Energy fuel cell system will begin operating in August and will reduce carbon emissions by 30 percent, increase energy reliability while also delivering cost savings.Read More

Date Posted: 07/19/12

Blog: Acquisition of Navigenics Expands Life Technologies' Capabilities in Diagnostics

Life Technologies Acquires Navigenics, Inc.

Life Technologies Announced - the acquisition of Navigenics, Inc. This acquisition represents the first step in executing against a strategy to build out its molecular diagnostics business through internal development, partnerships and select acquisitions.Read More

Date Posted: 07/17/12

Blog: Ethical Corporation Names Life Technologies' First CSO Sustainability Executive of the Year

Cristina Amorim recognized for leadership in driving strategic sustainability initiatives during annual awards ceremony in London

Chief Sustainability Officer, Cristina Amorim - has been named Sustainability Executive of the Year at the Ethical Corporation's annual Responsible Business Forum awards ceremony. She received the honor in recognition for her strategic role in Life's emergence as a Corporate Social Responsibility leader.Read More

Date Posted: 07/11/12

Blog: Gibco Hero for the Month of July - Dr. Zatz

Gibco 50th Anniversary

Congratulations Gibco Hero of the Month Dr. Zatz - We are proud to have Dr. Zatz featured as our “Cell Culture Hero” for the month of July. She is the professor and coordinator at the Genome Center Studies Center in Sao Paulo, Brazil. In addition to groundbreaking research, Dr. Zatz has been a champion of education and at the forefront of several key legislations that will help provide additional funding for scientific research in Latin America.Read More

Date Posted: 07/03/12

Blog: University of North Texas Health Science Center Advances Forensic Research by Investing in Semiconductor DNA Sequencing Technology

Advancing Forensic DNA Analysis

Life Technologies will Collaborate with the University of North Texas - Health Science Center’s Institute of Applied Genetics using the Ion Personal Genome Machine® (PGM™) system to further the university's research, development, and implementation of best technologies in forensic DNA analyses.Read More

Date Posted: 06/21/12

Blog: Life Technologies Signs Licensing Agreement with iPS Academia Japan for Global Patent Portfolio Rights to Induced Pluripotent Stem Cell Technology

New Agreement

Life Technologies today announced - that it has deepened its commitment to stem cell research and its customers by signing a non-exclusive agreement with iPS Academia Japan for its induced pluripotent stem (iPS) cell patent portfolio. The worldwide license will enable Life Technologies, a leading provider of innovative life science solutions, to expand its range of products and services for the iPS cell research community. Read More

Date Posted: 06/15/12

Blog: Life Technologies and Cellular Dynamics International Partner for Global Commercialization of Novel Stem Cell Technologies

Large-Scale Development of Human Pluripotent Stem Cells

New Partnership Announcement - Life Technologies today announced a partnership with Cellular Dynamics International (CDI), the world’s largest producer of human cells derived from induced pluripotent stem (iPS) cells, to commercialize a set of three new products optimized to consistently develop and grow human iPS cells for both research and bioproduction.Read More

Date Posted: 06/12/12

Blog: Susan Magdaleno Describes Silencer® Select siRNA Technology

Meet the Inventor

Susan Magdaleno - is a Senior Staff Scientist in the research and development department at Ambion, which is a part of Life Technologies. Susan was asked to describe Silencer® Select siRNA Technology. This is a recap of her reply...Read More

Date Posted: 06/11/12

Blog: Gibco Hero for the Month of June

Gibco 50th Anniversary

Congratulations Gibco Hero of the Month Dr. Yamanaka - We were honored to interview the father of induced pluripotent stem cells (iPSCs), about his journey and what he sees in the future for stem cell research.Read More

Date Posted: 06/07/12